Seminal calbindin 2 level in azoospermia and oligoasthenoteratozoospermia and its correlation with seminal and hormonal parameters.


Journal

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
ISSN: 2282-4197
Titre abrégé: Arch Ital Urol Androl
Pays: Italy
ID NLM: 9308247

Informations de publication

Date de publication:
15 Nov 2023
Historique:
received: 02 10 2023
accepted: 09 10 2023
medline: 9 1 2024
pubmed: 9 1 2024
entrez: 9 1 2024
Statut: epublish

Résumé

We aimed to assess seminal calbindin 2 (CALB 2) expression in men with different semen parameters as well as its correlation with reproductive hormones in azoospermic patients and different semen parameters in oligoasthenoteratozoospermic patients. CALB 2 is also known as calretinin and 29 kDa calbindin. This prospective study was performed on 96 cases from the andrology outpatient clinic divided into 3 groups as follows: group 1 including 32 non obstructive azoospermic (NOA) patients, group 2 including 32 patients with oligoasthenoteratozoospermia (OAT), and Group 3 including normozoospermic individuals as controls. Semen analysis and estimation of seminal CALB 2 concentrations by enzyme linked immunosorbent assay (ELISA) technique were performed for all participants. Reproductive hormones were measured in nonobstructive NOA patients. The mean seminal CALB 2 level was higher in OAT patients compared to NOA patients and controls (7.8 ± 1.30 ng/ml, 7.3 ± 0.80 and 7.4 ± 1.0, respectively). Furthermore, the study had shown strong positive correlations between CALB 2 and sperm normal forms in controls and OAT patients. In contrast, there was no significant correlation between seminal CALB 2 and any of the reproductive hormones measured in NOA patients. Seminal CALB 2 may play a role in increasing the abnormal forms in OAT patients.

Identifiants

pubmed: 38193226
doi: 10.4081/aiua.2023.11906
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11906

Auteurs

Sameh Fayek GamalEl Din (SF)

Department of Andrology, Sexology and STDs, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo. samehfayek@kasralainy.edu.eg.

Noha Abdelhafeez Abdelkader (N)

Department of Clinical and Chemical Pathology, Faculty of Medicine, Beni-Suef University, Beni-Suef. NOHA.ABDELKADER@med.bsu.edu.eg.

Mohamed Yousry El-Amir (MY)

Department of Andrology, Sexology and STDs, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo. Yousr82@kasralainy.edu.eg.

Asmaa Anter Sayed Ahmed (AA)

Egypt Ministry of Health & Population, Cairo. allahtaim2@gmail.com.

Hesham Fouad Abdel-Latif (HF)

Department of Andrology, Sexology and STDs, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo. Hisham.foaad@kasralainy.edu.eg.

Mohamed Farag Azmy (MF)

Department of Andrology, Sexology and STDs, Faculty of Medicine, Beni-Suef University, Beni-Suef. Mohamed.Azmy@med.bsu.edu.eg.

Classifications MeSH